[en] Myxoma virus (MYXV) induces a lethal disease called Myxomatosis in European rabbits. MYXV is one of the rare viruses that encodes an alpha2,3-sialyltransferase through its M138L gene. In this study, we showed that although the absence of the enzyme was not associated with any in vitro deficit, the M138L deficient strains are highly attenuated in vivo. Indeed, while all rabbits infected with the parental and the revertant strains died within 9 days post-infection from severe myxomatosis, all but one rabbit inoculated with the M138L deficient strains survived the infection. In primary lesions, this resistance to the infection was associated with an increased ability of innate immune cells, mostly neutrophils, to migrate to the site of virus replication at 4 days post-infection. This was followed by the development of a better specific immune response against MYXV. Indeed, at day 9 post-infection, we observed an important proliferation of lymphocytes and an intense congestion of blood vessels in lymph nodes after M138L knockouts infection. Accordingly, in these rabbits, we observed an intense mononuclear cell infiltration throughout the dermis in primary lesions and higher titers of neutralizing antibodies. Finally, this adaptive immune response provided protection to these surviving rabbits against a challenge with the MYXV WT strain. Altogether, these results show that expression of the M138L gene contributes directly or indirectly to immune evasion by MYXV. In the future, these results could help us to better understand the pathogenesis of myxomatosis but also the importance of glycans in regulation of immune responses.
Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends in microbiology. 2007; 15(5):211-8. doi: 10.1016/j.tim.2007.03.003 PMID: 17398101.
Markine-Goriaynoff N, Gillet L, Van Etten JL, Korres H, Verma N, Vanderplasschen A. Glycosyltransferases encoded by viruses. J Gen Virol. 2004; 85(Pt 10):2741-54. Epub 2004/09/28. 85/10/2741 [pii]. doi: 10.1099/vir.0.80320-0 PMID: 15448335.
Jackson RJ, Hall DF, Kerr PJ. Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence. Journal of virology. 1999; 73(3):2376-84. PMID: 9971821; PubMed Central PMCID: PMC104483.
Stanford MM, Werden SJ, McFadden G. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Veterinary research. 2007; 38(2):299-318. doi: 10.1051/vetres:2006054 PMID: 17296158.
Kerr PJ. Myxomatosis in Australia and Europe: a model for emerging infectious diseases. Antiviral research. 2012; 93(3):387-415. doi: 10.1016/j.antiviral.2012.01.009 PMID: 22333483.
Spiesschaert B, McFadden G, Hermans K, Nauwynck H, Van de Walle GR. The current status and future directions of myxoma virus, a master in immune evasion. Veterinary research. 2011; 42:76. doi: 10.1186/1297-9716-42-76 PMID: 21658227; PubMed Central PMCID: PMC3131250.
Kerr PJ, Ghedin E, DePasse JV, Fitch A, Cattadori IM, Hudson PJ, et al. Evolutionary history and attenuation of myxoma virus on two continents. PLoS pathogens. 2012; 8(10):e1002950. doi: 10.1371/journal.ppat.1002950 PMID: 23055928; PubMed Central PMCID: PMC3464225.
Kerr PJ, Rogers MB, Fitch A, Depasse JV, Cattadori IM, Hudson PJ, et al. Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations. Journal of virology. 2013; 87(22):12080-9. doi: 10.1128/JVI.01923-13 PMID: 23986601; PubMed Central PMCID: PMC3807925.
Kerr PJ, Rogers MB, Fitch A, Depasse JV, Cattadori IM, Twaddle AC, et al. Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread. Journal of virology. 2013; 87(23):12900-15. doi: 10.1128/JVI.02060-13 PMID: 24067966; PubMed Central PMCID: PMC3838154.
Li Y, Chen X. Sialic acid metabolism and sialyltransferases: natural functions and applications. Applied microbiology and biotechnology. 2012; 94(4):887-905. doi: 10.1007/s00253-012-4040-1 PMID: 22526796; PubMed Central PMCID: PMC3534974.
Sujino K, Jackson RJ, Chan NW, Tsuji S, Palcic MM. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors. Glycobiology. 2000; 10(3):313-20. PMID: 10704530.
Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Annals of the New York Academy of Sciences. 2012; 1253:16-36. doi: 10.1111/j.1749-6632.2012.06517.x PMID: 22524423; PubMed Central PMCID: PMC3357316.
Sugiarto G, Lau K, Yu H, Vuong S, Thon V, Li Y, et al. Cloning and characterization of a viral alpha2-3-sialyltransferase (vST3Gal-I) for the synthesis of sialyl Lewisx. Glycobiology. 2011; 21(3):387-96. doi: 10.1093/glycob/cwq172 PMID: 20978012; PubMed Central PMCID: PMC3033747.
Nash P, Barry M, Seet BT, Veugelers K, Hota S, Heger J, et al. Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase. The Biochemical journal. 2000; 347(Pt 2):375-82. PMID: 10749666; PubMed Central PMCID: PMC1220969.
Chakrabarti S, Sisler JR, Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques. 1997; 23(6):1094-7. PMID: 9421642.
Johnston JB, Barrett JW, Chang W, Chung CS, Zeng W, Masters J, et al. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. Journal of virology. 2003; 77(10):5877-88. PMID: 12719581; PubMed Central PMCID: PMC154029.
Machiels B, Stevenson PG, Vanderplasschen A, Gillet L. A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization. PLoS Pathog. 2013; 9(10):e1003753. doi: 10.1371/journal.ppat.1003753 PMID: 24204281; PubMed Central PMCID: PMC3814654.
Machiels B, Lete C, Guillaume A, Mast J, Stevenson PG, Vanderplasschen A, et al. Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog. 2011; 7(11):e1002387. doi: 10.1371/journal.ppat.1002387 PMID: 22114560; PubMed Central PMCID: PMC3219721.
Blanie S, Mortier J, Delverdier M, Bertagnoli S, Camus-Bouclainville C. M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit. Veterinary research. 2009; 40 (1):11. doi: 10.1051/vetres:2008049 PMID: 19019281; PubMed Central PMCID: PMC2695013.
Hirsch RL, Griffin DE, Winkelstein JA. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. Journal of immunology. 1981; 127 (5):1740-3. PMID: 6117595.
Hirsch RL, Griffin DE, Winkelstein JA. Natural immunity to Sindbis virus is influenced by host tissue sialic acid content. Proceedings of the National Academy of Sciences of the United States of America. 1983; 80(2):548-50. PMID: 6300853; PubMed Central PMCID: PMC393416.
McSharry JJ, Pickering RJ, Caliguiri LA. Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid. Virology. 1981; 114(2):507-15. PMID: 6270885.
Liu J, Wennier S, Reinhard M, Roy E, MacNeill A, McFadden G. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits. Journal of virology. 2009; 83(11):5933-8. doi: 10.1128/JVI.00204-09 PMID: 19279088; PubMed Central PMCID: PMC2681933.
Zou Z, Chastain A, Moir S, Ford J, Trandem K, Martinelli E, et al. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PloS one. 2011; 6(9):e24559. doi: 10.1371/journal.pone.0024559 PMID: 21931755; PubMed Central PMCID: PMC3169630.
Fenner F, Marshall ID. A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. The Journal of hygiene. 1957; 55(2):149-91. PMID: 13439170; PubMed Central PMCID: PMC2217926.
Best SM, Collins SV, Kerr PJ. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Virology. 2000; 277(1):76-91. doi: 10.1006/viro.2000.0505 PMID: 11062038.
Best SM, Kerr PJ. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology. 2000; 267(1):36-48. doi: 10.1006/viro.1999.0104 PMID: 10648181.
Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nature reviews Immunology. 2011; 11(8):519-31. doi: 10.1038/nri3024 PMID: 21785456.
Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. The Journal of experimental medicine. 2013; 210(7):1283-99. doi: 10.1084/jem.20122220 PMID: 23825232; PubMed Central PMCID: PMC3698517.
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nature reviews Immunology. 2013; 13(3):159-75. doi: 10.1038/nri3399 PMID: 23435331.
Nauseef WM, Borregaard N. Neutrophils at work. Nature immunology. 2014; 15(7):602-11. doi: 10.1038/ni.2921 PMID: 24940954.
Gabriel C, Her Z, Ng LF. Neutrophils: neglected players in viral diseases. DNA and cell biology. 2013; 32(12):665-75. doi: 10.1089/dna.2013.2211 PMID: 24236425.
Stacey MA, Marsden M, Pham NT, Clare S, Dolton G, Stack G, et al. Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. Cell host & microbe. 2014; 15(4):471-83. doi: 10.1016/j.chom.2014.03.003 PMID: 24721575; PubMed Central PMCID: PMC3989063.
Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA, et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell host & microbe. 2013; 13(2):169-80. doi: 10.1016/j.chom.2013.01.005 PMID: 23414757.
van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. The Journal of experimental medicine. 2005; 201(8):1281-92. doi: 10.1084/jem.20041276 PMID: 15837813; PubMed Central PMCID: PMC2213143.
Eken C, Gasser O, Zenhaeusern G, Oehri I, Hess C, Schifferli JA. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. Journal of immunology. 2008; 180(2):817-24. PMID: 18178820.
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature immunology. 2012; 13(2):170-80. doi: 10.1038/ni.2194 PMID: 22197976; PubMed Central PMCID: PMC3262910.
Charmoy M, Brunner-Agten S, Aebischer D, Auderset F, Launois P, Milon G, et al. Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS pathogens. 2010; 6(2):e1000755. doi: 10.1371/journal.ppat.1000755 PMID: 20140197; PubMed Central PMCID: PMC2816696.
Bennouna S, Bliss SK, Curiel TJ, Denkers EY. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. Journal of immunology. 2003; 171(11):6052-8. PMID: 14634118.
Morel C, Badell E, Abadie V, Robledo M, Setterblad N, Gluckman JC, et al. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice. European journal of immunology. 2008; 38(2):437-47. doi: 10.1002/eji.200737905 PMID: 18203135.
Duffy D, Perrin H, Abadie V, Benhabiles N, Boissonnas A, Liard C, et al. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells. Immunity. 2012; 37 (5):917-29. doi: 10.1016/j.immuni.2012.07.015 PMID: 23142782.
Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proceedings of the National Academy of Sciences of the United States of America. 1990; 87(10):3982-6. PMID: 1692629; PubMed Central PMCID: PMC54028.
Favoreel HW, Van de Walle GR, Nauwynck HJ, Pensaert MB. Virus complement evasion strategies. The Journal of general virology. 2003; 84(Pt 1):1-15. PMID: 12533696.
Nakagawa K, Kitazume S, Oka R, Maruyama K, Saido TC, Sato Y, et al. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. Journal of neurochemistry. 2006; 96(4):924-33. doi: 10.1111/j.1471-4159.2005.03595.x PMID: 16412100.
Richards AA, Colgrave ML, Zhang J, Webster J, Simpson F, Preston E, et al. Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Molecular endocrinology. 2010; 24(1):229-39. doi: 10.1210/me.2009-0133 PMID: 19855092.
Lucas A, McFadden G. Secreted immunomodulatory viral proteins as novel biotherapeutics. Journal of immunology. 2004; 173(8):4765-74. PMID: 15470015.
Lalani AS, Masters J, Graham K, Liu L, Lucas A, McFadden G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology. 1999; 256 (2):233-45. doi: 10.1006/viro.1999.9617 PMID: 10191189.
Lalani AS, Ness TL, Singh R, Harrison JK, Seet BT, Kelvin DJ, et al. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 1998; 250(1):173-84. doi: 10.1006/viro.1998.9340 PMID: 9770431.
Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, Kelvin D, et al. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. Journal of virology. 1997; 71(6):4356-63. PMID: 9151824; PubMed Central PMCID: PMC191652.
Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 1996; 215(1):17-30. doi: 10.1006/viro.1996.0003 PMID: 8553583.
Mossman K, Upton C, McFadden G. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. The Journal of biological chemistry. 1995; 270(7):3031-8. PMID: 7852384.
Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 1992; 258(5086):1369-72. PMID: 1455233.
Macen JL, Upton C, Nation N, McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 1993; 195(2):348-63. doi: 10.1006/viro.1993.1385 PMID: 8337817.
Audry M, Jeanneau C, Imberty A, Harduin-Lepers A, Delannoy P, Breton C. Current trends in the structure-activity relationships of sialyltransferases. Glycobiology. 2011; 21(6):716-26. doi: 10.1093/glycob/cwq189 PMID: 21098518.